Post-effective amendment to a registration statement that is not immediately effective upon filing

Earnings (Loss) per Share - Anti-dilutive securities (Details)

v3.22.2.2
Earnings (Loss) per Share - Anti-dilutive securities (Details) - P3 Health Partners Inc. - shares
 1 Months Ended 3 Months Ended 6 Months Ended 11 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 02, 2021
Dec. 31, 2020
Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                    
Financial Designation, Predecessor and Successor [Fixed List] Successor Successor Successor Predecessor Predecessor Successor Predecessor Predecessor Predecessor Predecessor
Potentially dilutive securities excluded from the computation of diluted net loss per share   16,290,567       13,554,998        
Public Warrants                    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                    
Potentially dilutive securities excluded from the computation of diluted net loss per share   10,541,667       10,591,605        
Private Warrants                    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                    
Potentially dilutive securities excluded from the computation of diluted net loss per share   277,500       227,500        
Restricted Shares                    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                    
Potentially dilutive securities excluded from the computation of diluted net loss per share   5,471,400       601,614        
Time-based options                    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                    
Potentially dilutive securities excluded from the computation of diluted net loss per share           2,134,279